Monday, December 23, 2024
HomeTagsSCHIZOPHRENIA

SCHIZOPHRENIA

Maplight Therapeutics Announces Initiation of Phase 1 Clinical Trial for Novel Therapy

MapLight Therapeutics announced it has initiated a Phase 1 clinical trial evaluating ML-007, a novel therapeutic developed to target circuits understood to be dysfunctional...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics